US 12209135
Anti-CD45 antibodies and conjugates thereof
granted A61KA61K2035/124A61K2039/505
Quick answer
US patent 12209135 (Anti-CD45 antibodies and conjugates thereof) held by Vor Biopharma Inc. expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vor Biopharma Inc.
- Grant date
- Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2035/124, A61K2039/505, A61K35/28, A61K47/6803